Biobanking Industry Is Driven By Growing Investments For R&D Of Advanced Therapies
Biobanking Industry Data Book Covers Biobanks, Cell Banking Outsourcing, Cord Blood Banking Services, DNA & RNA Banking Services Markets.
Biobanks market was valued at USD 66.06 Billion in 2021 with CAGR of 4.6% during 2022-2030. Cell banking outsourcing market projected to grow at the CAGR of 16.39%. Biobanks and biorepositories provide biological resources that aid in effective translation of biomedical research.
Access the Global Biobanking Industry Data Book, 2023 to 2030, compiled with details like market sizing information & forecasts, trade data, pricing intelligence, competitive benchmarking, macro-environmental analyses, and regulatory & technological framework studies.
Biobanks Market Growth & Trends
The global biobanks market size is expected to reach USD 136.9 billion by 2030, according to a new report by Grand View Research, Inc., registering a CAGR of 8.6% during the forecast period. Biobanks continue to evolve with the introduction of new technologies, such as NGS, and increased focus on genomic medicine. The availability of several types of biospecimens to cater to multiple domains including drug discovery, diagnostics, and others has accelerated the diversification of biorepositories, thereby driving the market. The quality of biospecimens can significantly influence disease testing as well as preclinical and clinical research. Regulatory agencies have played a vital role in spurring the adoption of biobanking services by establishing guidelines for the effective management of samples.
For instance, the U.S. Centers for Disease Control and Prevention (CDC) released guidelines to minimize human hazards while handling COVID-19 samples. This serves as a model for other biorepositories. Furthermore, as the number of research studies and clinical trials related to COVID-19 is increasing, the demand for high-quality biospecimens is expected to significantly increase in the near future, leading to market growth. In addition, population-based cohort studies are facilitated by biorepositories to estimate the actual seroprevalence. Health Catalyst, Inc., through its Touchstone platform, provides national data related to COVID-19 insights. Such factors are anticipated to contribute to the revenue flow in this space.
Cell Banking Outsourcing Market Growth & Trends
The global cell banking outsourcing market size is expected to reach USD 35.59 billion by 2030, registering a CAGR of 16.34%, according to a new report by Grand View Research, Inc. Introduction of novel technologies for the collection, testing, and storage of cell lines are expected to boost the cell banking market during the forecast period. Automation in cord blood processing and storage are the key technologies that are expected to affect the growth of the market.
CellTrials.org found that global enrolments of new trials in advanced cell therapy were up almost 30% in the first quarter of 2020. Most of the rise can be associated with cell therapy efforts for treating COVID-19, and over half of those trials for COVID-19 employ umbilical cord MSCs. Hence, the pandemic has created a new market for those companies which are engaged in the manufacturing of MSCs products.
According to a report published by Pharma Intelligence UK Limited, 21 oncological drugs are expected to be launched in 2022. Moreover, these drugs will be used for the treatment of different metabolic disorders which would result in the increased entry of novel biosimilar drugs into the market during the forecast period. For instance, in 2022, Center for Drug Evaluation and Research (CDER), approved 15 new drugs and biological products. Cell lines are highly valuable assets for the production and testing of these biopharmaceuticals. Hence, the increasing number of R&D activities for biosimilar and biologic products is expected to increase demand for the good-quality cell lines, thereby, fueling the demand for banking services.
Order your copy of Free Sample of “Biobanking Industry Data Book - Biobanks, Cell Banking Outsourcing, Cord Blood Banking Services, DNA & RNA Banking Services Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030” Data Book, published by Grand View Research
Cord Blood Banking Services Market Growth & Trends
Cord blood is the blood that is left post-delivery in the placenta and umbilical cord. Cord blood is collected from umbilical cord just after the child is born. It is a rich source of stem cells, which have the ability to differentiate into a range of cell types. Cord blood banking services involve the collection of cord blood and cryogenically freezing the stem cells, as well as other immune system cells, so that they can be preserved for medical uses in future. Cord blood banking is commonly referred to as ‘stem cell banking’ in Europe as well as some other parts of the world.
Cord blood is often referred to as regenerative medicine, as they help in regeneration of various stems and tissues. Stem cells with high proliferation capacity possess low risk of tumor formation and viral contamination. With stem cells rapidly becoming the choice of treatment for patients suffering from life-threatening conditions such as cancer and blood, metabolic and immune system disorders, cord blood banking services have gained much prominence in the healthcare sector.
DNA & RNA Banking Services Market Growth & Trends
The global DNA and RNA banking services market size is expected to reach USD 8.83 billion by 2027, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.46% from 2021 to 2027. Biospecimens such as DNA and RNA are critical for biomarker discovery, thereby providing a path for the expansion of personalized medicine. Moreover, progress in translational and clinical research through an introduction of advanced, standardized cell isolation methodologies reduces hands-on-time. The development of automated solutions and the transformation of biobanks into fully automated biobanks potentially accelerate the growth of the market.
A rise in the enrollment of individuals for personalized medicine initiatives drives the revenue generation for DNA and RNA banking services. In July 2019, Partners HealthCare, U.S. enrolled more than 100,000 individuals in its precision medicine biobank that supported clinicians and researchers of the Brigham and Women’s Hospital, U.S., and other partners. Such initiative assisted in examining the impact of several factors on disease and health.
Go through the table of content of Biobanking Industry Data Book to get a better understanding of the Coverage & Scope of the study.
Competitive Landscape
Key players operating in the Biobanking Industry are –
• DANAHER CORPORATIONDANAHER CORPORATION • Tecan Trading AG. • THERMO FISHER SCIENTIFIC, INC. • QIAGEN • MERCK KGAA • HAMILTON COMPANY • BECTON, DICKINSON AND COMPANY • AVANTOR • PROMOCELL GMBH • BIOCISION • CHARLES RIVER LABORATORIES • BIOVAULT FAMILY • LONZA GROUP AG • BIO RELIANCE • STEMCELL TECHNOLOGIES INC. • BIO OUTSOURCE (SARTORIOUS) • BSL BIOSERVICE • CRYO-CELL INTERNATIONAL, INC • COVANCE • GLOBAL STEM INC. • GOODWIN BIOTECHNOLOGY INC. • SGS LIFE SCIENCES • CHINA CORD BLOOD CORPORATION • CORD BLOOD AMERICA, INC. • CBR SYSTEMS, INC. • CRYO-SAVE AG • LIFEFORCE CRYOBANKS • NATIONAL CORD BLOOD PROGRAM • VIACORD, INC. • VIRGIN HEALTH BANK • EASYDNA
Grand View Research’s Biobanking industry data book is a collection of market sizing information & forecasts, regulatory data, competitive benchmarking analyses, macro-environmental analyses, and technological framework studies. Within the purview of the database, all such information is systematically analyzed and provided in the form of presentations and detailed outlook reports on individual areas of research.
About Grand View Research
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
Comments